Mesoblast
MESO
#4325
Rank
A$3.66 B
Marketcap
A$28.45
Share price
4.31%
Change (1 day)
67.95%
Change (1 year)

Mesoblast (MESO) - Net assets

Net assets on the balance sheet as of June 2025 : A$0.89 Billion

According to Mesoblast 's latest financial reports the company has A$0.89 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Mesoblast - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$A$0.71 B-4.42%
2023-06-30$A$0.75 B4.5%
2022-06-30$A$0.72 B-7.07%
2021-06-30$A$0.77 B-2.57%
2020-06-30$A$0.79 B16.2%
2019-06-30$A$0.68 B-7.13%
2018-06-30$A$0.73 B9.58%
2017-06-30$A$0.67 B-5.07%
2016-06-30$A$0.70 B16.57%
2015-06-30$A$0.60 B0.32%
2014-06-30$A$0.60 B-12.18%
2013-06-30$A$0.69 B47.67%
2012-06-30$A$0.46 B-2.86%
2011-06-30$A$0.48 B975.08%
2010-06-30$A$44.76 M40.43%
2009-06-30$A$31.87 M16.3%
2008-06-30$A$27.41 M13.01%
2007-06-30$A$24.25 M49.95%
2006-06-30$A$16.17 M-35.92%
2005-06-30$A$25.24 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NRC Health
NRC
A$21.55 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-A$4.34 Million-100.48% Bahamas